NCT05524389: Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions
- State
- Not started
- Phase
- Phase 3
- People
- 624 planned
- Started
- 1 Dec 2022
- Primary completion
- 1 Dec 2026
- Arms
- Molecular classification based treatment
- Results
- None posted
- 1 Sep 2022: Trial registered